Search

Author/Creator Petrovic, Romana

1. 1768. Efficacy and Safety of Switching From Boosted-Protease Inhibitors (bPI) Plus Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) Regimens to the Once Daily (QD), Single-Tablet Regimen (STR) of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Virologically Suppressed, HIV-1-Infected Adults: Week 96 Results of the Phase 3, Randomized, Non-Inferiority EMERALD Trial. (26th November 2018)

Authors:
Eron, Joseph; Orkin, Chloe; Cunningham, Douglas; Pulido, Federcio; Post, Frank; De Wit, Stéphane; Lathouwers, Erkki; Hufkens, Veerle; Petrovic, Romana; Van Landuyt, Erika
Journal:
Open forum infectious diseases
Issue:
Volume 5(2018)Supplement 1
Page Start:
S65
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide at 48 weeks in adults with virologically suppressed HIV-1 (EMERALD): a phase 3, randomised, non-inferiority trial. Issue 1 (January 2018)

Authors:
Orkin, Chloe; Molina, Jean-Michel; Negredo, Eugenia; Arribas, José R; Gathe, Joseph; Eron, Joseph J; Van Landuyt, Erika; Lathouwers, Erkki; Hufkens, Veerle; Petrovic, Romana; Vanveggel, Simon; Opsomer, Magda
Journal:
Lancet
Issue:
Volume 5:Issue 1(2018)
Page Start:
e23
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. NADPH oxidase and redox status in amygdala, hippocampus and cortex of male Wistar rats in an animal model of post-traumatic stress disorder. (2nd November 2018)

Authors:
Petrovic, Romana; Puskas, Laslo; Jevtic Dozudic, Gordana; Stojkovic, Tihomir; Velimirovic, Milica; Nikolic, Tatjana; Zivkovic, Milica; Djorovic, Djordje J.; Nenadovic, Milutin; Petronijevic, Natasa
Journal:
Stress
Issue:
Volume 21:Number 6(2018:Nov.)
Page Start:
494
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Pharmacokinetics of darunavir in fixed‐dose combination with cobicistat compared with coadministration of darunavir and ritonavir as single agents in healthy volunteers. (26th March 2014)

Authors:
Kakuda, Thomas N.; Opsomer, Magda; Timmers, Maarten; Iterbeke, Koen; Van De Casteele, Tom; Hillewaert, Vera; Petrovic, Romana; Hoetelmans, Richard M. W.
Journal:
Journal of clinical pharmacology
Issue:
Volume 54:Number 8(2014:Aug.)
Page Start:
949
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Week 48 Results of EMERALD: A Phase 3, Randomized, Non-inferiority Study Evaluating the Efficacy and Safety of Switching from Boosted-protease Inhibitors (bPI) Plus Emtricitabine (FTC)/Tenofovir Disoproxil Fumarate (TDF) Regimens to the Once Daily (QD), Single-tablet Regimen (STR) of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Virologically Suppressed, HIV-1-infected Adults. (4th October 2017)

Authors:
Orkin, Chloe; Molina, Jean-Michel; Gallant, Joel; Negredo, Eugenia; Gathe, Joseph; Eron, Joseph; Van Landuyt, Erika; Lathouwers, Erkki; Hufkens, Veerle; Petrovic, Romana; Opsomer, Magda
Journal:
Open forum infectious diseases
Issue:
Volume 4(2017)Supplement 1
Page Start:
S737
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗